The Cross-Border Biotech Investment & BD Forum By BioKatalyst
During the world’s premier biotech gathering, BIO International Convention, BioKatalyst and Biolink Capital invite you to an exclusive, high-impact forum bringing together biotech innovators, pharmaceutical executives, investors, and cross-border dealmakers shaping the future of global healthcare.Designed for biotech leaders, investors, and dealmakers navigating today’s increasingly complex U.S.–China landscape, this curated forum creates a rare space for strategic dialogue, cross-border partnership discussions, and high-value executive networking at a pivotal moment for the global biotech industry.
Why Attend
▸ Investment Insights
Gain front-line perspectives from leading biotech investors and industry experts on:
- Emerging biotech investment themes
- Next-generation R&D trends
- Global capital flow and licensing dynamics
- Therapeutic areas expected to define the next decade
▸ Strategic Cross-Border BD Perspectives
Hear directly from pharma executives, investors, and transaction leaders on:
- Cross-border licensing strategies
- U.S.–China biotech collaboration models
- Partnering, co-development, and commercialization pathways
- Navigating today’s evolving geopolitical and capital environment
▸ Curated Executive Networking
Move beyond crowded convention halls and engage in focused conversations with:
- Forum Agenda
- Biotech founders
- Pharma business development leaders
- Venture capital and PE investors
- Strategic advisors and ecosystem builders
2:45PM – 2:50 PM
Opening Remarks — Jansen Wang, BioKatalyst President
2:50PM – 3:00 PM
Biolink Capital Introduction— Leo Jia, Cofounder of Biolink Capital
3:00 PM – 3:40 PM
Panel Discussion
The Emerging New Logic of Cross-Border Biotech Investment
Panelists
- Sean Hu — CEO, Rapafusyn Pharmaceuticals
- Lily Zou — CEO & Co-Founder, Degron Therapeutics
- Gagareth Higgs — Partner, Advantary Capital Partners
- Han Zhang — Managing Director, Boston Capital Investment Club
- David Chen— Founder, Princeton Venture Studio
Moderator
- Vivian Li — Early-Stage Investor, K2VC
3:40 PM – 4:00 PM
Sponsor Keynote Session
Leveraging the quality, rapid turnaround, and unique collaboration models of Chinese CROs for drug discovery and development
Speaker
- Chunlin Chen — Founder, Chairman & CEO, Medicilon
Featured Sponsor
- Medicilon
4:00 PM – 4:15 PM
Networking Break
Open networking and curated business matching
4:15 PM – 4:35 PM
Keynote Presentation
China’s Innovative Drug R&D and Cross-Border Transaction Trends
Speaker
- Zairan Liu — Chief International Business Officer, PharmCube
4:35 PM – 5:15 PM
Panel Discussion
The New Logic of Cross-Border Biotech BD
Panelists
- John Wang — SVP & Chief Strategy Officer, Gan & Lee Pharmaceutical
- Hai Dai — Chief Innovation Officer & Head of Investment, Viva Biotech
- Mingfeng Bai — SVP, Business Development, Medicilon
- Peter J. Butch III — Partner, Fox Rothschild
- Leon Tang — Founding Partner, ISWT BioAdvisory /VP Business Development, Mianus Accelerator
Moderator
- Seamus Jiang — Managing Director, China/U.S. Cross-Border Deals Leader, PwC
5:15 PM – 6:00 PM
Executive Networking Reception
Wine, refreshments, and open networking with founders, investors, and industry leaders.
